Onderzoeker
Gert De Meerleer
- Disciplines:Morfologische wetenschappen
Affiliaties
- Vakgroep Structuur en Herstel van de Mens (Departement)
Lid
Vanaf1 okt 2018 → 31 mei 2020 - Vakgroep Radiotherapie en Experimenteel Kankeronderzoek (Departement)
Lid
Vanaf1 okt 2000 → 30 sep 2018
Publicaties
1 - 10 van 98
- A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy(2021)
Auteurs: Miha Orazem, Cedric Draulans, Mathieu Spaas, Eric Van Cutsem, Marina Debecker, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans
Pagina's: 1121 - 1125 - A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer(2020)
Auteurs: Elise De Bleser, Ruben Willems, Karel Decaestecker, Lieven Annemans, Aurélie De Bruycker, Valerie Fonteyne, Nicolaas Lumen, Filip Ameye, Ignace Billiet, Steven Joniau, et al.
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants(2018)
Auteurs: Tokhir Dadaev, Edward J. Saunders, Paul J. Newcombe, Ezequiel Anokian, Daniel A. Leongamornlert, Mark N. Brook, Clara Cieza-Borrella, Martina Mijuskovic, Sarah Wakerell, Ali Amin Al Olama, et al.
- Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al(2018)
Auteurs: Piet Ost, Dries Reynders, Karel Decaestecker, Valerie Fonteyne, Nicolaas Lumen, Bieke Lambert, Louke Delrue, Gert De Meerleer
Pagina's: 2351 - 2352 - Whole pelvis radiotherapy for pathological node-positive prostate cancer(2017)
Auteurs: Filip Poelaert, Piet Ost, Bart De Troyer, Gert De Meerleer, Pieter De Visschere, Tom Claeys, Nicolaas Lumen
Pagina's: 444 - 451 - The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients(2016)
Auteurs: Annelies Van Hemelryk, Gert De Meerleer, Piet Ost, Filip Poelaert, Werner De Gersem, Pieter De Visschere, Valérie Fonteyne
Pagina's: 323 - 332 - Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire(2015)
Auteurs: Julie Devos, Valérie Fonteyne, Veerle Decalf, Gert De Meerleer, Piet Ost, Nicolaas Lumen
Pagina's: 272 - 279 - How bad is the outcome of node positive prostate cancer patients: a matched case analysis between N+ and N0 prostate cancer patients(2015)Volume: 14
Auteurs: Valérie Fonteyne, Annelies Van Hemelryk, Nicolaas Lumen, Piet Ost, Pieter De Visschere, Gert De Meerleer
Pagina's: 174 - 175 - Radiotherapy for renal-cell carcinoma(2014)
Auteurs: Gert De Meerleer, Vincent Khoo, Bernard Escudier, Steven Joniau, Alberto Bossi, Piet Ost, Alberto Briganti, Valérie Fonteyne, Marco Van Vulpen, Nicolaas Lumen, et al.
Pagina's: e170 - e177 - Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial(2014)
Auteurs: Gert De Meerleer, Filip Ameye, Valérie Fonteyne, Bieke Lambert, Steven Joniau, Louke Delrue, Ignace Billiet, Wim Duthoy, Sarah Junius, Wouter Huysse, et al.